Gazyva (obinutuzumab)

pCPA File Number: 20806
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic Lymphocytic Leukemia: As monotherapy for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: